A detailed history of Walker Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Walker Asset Management, LLC holds 2,334 shares of ABBV stock, worth $427,308. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,334
Previous 2,353 0.81%
Holding current value
$427,308
Previous $403,000 14.14%
% of portfolio
0.31%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $3,112 - $3,787
-19 Reduced 0.81%
2,334 $460,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $3,250 - $3,795
21 Added 0.9%
2,353 $403,000
Q1 2024

Apr 10, 2024

BUY
$159.82 - $182.1 $3,036 - $3,459
19 Added 0.82%
2,332 $424,000
Q4 2023

Jan 08, 2024

BUY
$137.6 - $154.97 $318,268 - $358,445
2,313 New
2,313 $358,000
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $4.41 Million - $5.6 Million
32,035 New
32,035 $4.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Walker Asset Management, LLC Portfolio

Follow Walker Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walker Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walker Asset Management, LLC with notifications on news.